SIZONORM INJECTION contains Fluphenazine which belongs to the group of medicines called Antipsychotic drugs. It is used to manage chronic schizophrenia in patients who require prolonged parenteral neuroleptic therapy. Schizophrenia is a serious type of mental disorder in which the ability to interpret reality gets impaired. It is characterized by symptoms such as hallucinations, abnormal thoughts, delusions and extremely disordered behaviour.
SIZONORM INJECTION is not recommended for use if you have severe liver disorders, suspected or established subcortical brain damage, severely depressed states/coma, prolactin dependent tumors (like breast cancer, prolactinoma), Parkinson's disease, severe blood cell (leucopenia) or bone marrow damage or history of neuroleptic malignant syndrome.
Avoid consumption of alcohol while receiving this medicine. Before receiving this medicine, inform your doctor if you have slow heartbeat issues, pre-existing damage to heart, congenital/family history of prolonged QT interval, coronary heart disease, conduction disturbance and arrhythmia.
Also inform your doctor if you have chronic respiratory disorders, asthma, liver or kidney dysfunction, adrenal tumor, very low or high blood pressure, low potassium levels, history of organic brain disorders, epileptic seizures, depression or reduced consciousness. SIZONORM INJECTION should be used with caution in patients who are exposed to high temperature, have glaucoma, enlarged prostate, trouble passing urine or narrowing of opening from stomach to duodenum.
SIZONORM INJECTION should be used with caution in pregnant women. It is not recommended for use in breastfeeding women. It is not recommended for use in children (aged below 12 years). It should be used with caution in elderly patients (aged 65 years and above) especially dementia-related psychosis as it may increase the risk of dementia. The common side effects associated with the use of SIZONORM INJECTION are dyskinesia (muscle...
No content available
